12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers Tevogen Bio Holdings (NASDAQ:TVGN) shares rose 75.3% to $1.49 during Friday’s pre-market session. The company’s market cap…
12 Health Care Stocks Moving In Wednesday’s Intraday Session
Gainers EUDA Health Holdings (NASDAQ:EUDA) shares rose 45.3% to $2.14 during Wednesday’s regular session. As of 13:30 EST,…
Looking Into Cryo-Cell International’s Return On Capital Employed
According to Benzinga Pro data Cryo-Cell International (NASDAQ:CCEL) posted a 8.48% decrease in earnings from Q4. Sales, however,…
Cryo-Cell Reports Financial Results For Fiscal Year Ended November 30, 2022; EPS $0.33 Vs $0.25 YoY; Revenues Of $30.3M Vs $28.9M YoY
Revenue
Consolidated revenues for fiscal 2022 were $30.3 million compared to $28.9 million for fiscal 2021. The revenues for fiscal 2022 consisted of $29.8 million in processing and storage
Maxim Group Initiates Coverage On Cryo-Cell International with Buy Rating, Announces Price Target of $12
Maxim Group analyst Allen Klee initiates coverage on Cryo-Cell International (NASDAQ:CCEL) with a Buy rating and announces Price Target of $12.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 61 companies made new 52-week lows.
Cryo-Cell International Q2 EPS $0.08 Down From $0.14 YoY, Sales $7.63M Up From $7.21M YoY
Cryo-Cell International (NASDAQ:CCEL) reported quarterly earnings of $0.08 per share. This is a 42.86 percent decrease over earnings of $0.14 per share from the same period last year. The company reported $7.63 million
